CONGENITAL CYTOMEGALOVIRUS - IMMUNOLOGICAL ALTERATIONS

[1] ABO T, 1981, J IMMUNOL, V127, P1024

[2] Alford CA, 1980, PERINATAL INFECT, P125

[3] CARNEY WP, 1983, J IMMUNOL, V130, P390

[4] CARNEY WP, 1981, J IMMUNOL, V126, P2114

[5] CHARACTERIZATION OF HUMAN-LYMPHOCYTE SUBPOPULATIONS - ALLOREACTIVE CYTO-TOXIC LYMPHOCYTE-T PRECURSOR AND EFFECTOR-CELLS ARE PHENOTYPICALLY DISTINCT FROM LEU-2+ SUPPRESSOR CELLS [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1984, 4 (05) : 395 - 402

[6] GATENBY PA, 1982, J IMMUNOL, V129, P1997

[7] GEHRZ RC, 1985, CLIN EXP IMMUNOL, V61, P80

[8] GEHRZ RC, 1977, LANCET, V2, P844

[9] LANDAY A, 1984, BLOOD, V63, P1067

[10] LANDAY A, 1983, J IMMUNOL, V131, P2752

[1] ABO T, 1981, J IMMUNOL, V127, P1024

[2] Alford CA, 1980, PERINATAL INFECT, P125

[3] CARNEY WP, 1983, J IMMUNOL, V130, P390

[4] CARNEY WP, 1981, J IMMUNOL, V126, P2114

[5] CHARACTERIZATION OF HUMAN-LYMPHOCYTE SUBPOPULATIONS - ALLOREACTIVE CYTO-TOXIC LYMPHOCYTE-T PRECURSOR AND EFFECTOR-CELLS ARE PHENOTYPICALLY DISTINCT FROM LEU-2+ SUPPRESSOR CELLS [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1984, 4 (05) : 395 - 402

[6] GATENBY PA, 1982, J IMMUNOL, V129, P1997

[7] GEHRZ RC, 1985, CLIN EXP IMMUNOL, V61, P80

[8] GEHRZ RC, 1977, LANCET, V2, P844

[9] LANDAY A, 1984, BLOOD, V63, P1067

[10] LANDAY A, 1983, J IMMUNOL, V131, P2752